Senior insider sale
SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.35M
38.89K shares
What this filing means
GEMAYEL GEORGES plans to sell 38.89K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $1.35M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/8/2024ACC: 0001950047-24-008292
Director
Since Feb 2026
38.89K
Shares to sell
$1.35M
Approx. market value
10.79K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
11/8/2024
10.79KTotal acquired10.79K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/8/2024 | Exercise of options under a registered plan Cash | 10.79K | — |
| Total | 10.79K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
14.21K
Market value
$520.5K
11/7/2024
—Completed
Units to sell
13.89K
Market value
$435.0K
9/13/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.79K
Market value
$391.5K
11/8/2024
Total
Units
38.89K
Value
$1.35M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/7/2024 | 14.21K | $520.5K | — | Completed |
9/13/2024 | 13.89K | $435.0K | — | Completed |
| Planned — Approximate Date | ||||
11/8/2024 | 10.79K | $391.5K | NASDAQ | Planned |
| Total | 38.89K | $1.35M | ||